Condition

Insulin Secretion

ClinicalTrials.gov condition label

Clinical trials6

Recruiting1

Common interventions10

Lead sponsors shown5

Clinical trials

6 shown

Intermittent Fasting to Improve Insulin SecretionNCT04607096 · 2021-04-08

RECRUITING

Effect of Taking a Single Tablet of Iron on Insulin SecretionNCT05238987 · 2020-10-10

COMPLETED

Glucagon Regulation of Glucose MetabolismNCT04347252 · 2019-09-24

COMPLETED

Regulation of Insulin Secretion by the GLP-1 ReceptorNCT02844907 · 2018-07-01

TERMINATED

Incretin Action in Physiology and DiabetesNCT02550548 · 2016-04-21

COMPLETED

Maternal GDM in Hispanic Youth: Risk for ObesityNCT02668601 · 2010-08-01

COMPLETED

Common interventions

Control dietBEHAVIORAL1DexamethasoneDRUG1Ex-9 infusionDRUG1Exendin (9-39)DRUG1Ferrous sulphateDIETARY_SUPPLEMENT1GIP infusionDRUG1GLP-1 infusionDRUG1GlucagonDRUG1Hyperglycemic ClampOTHER1Intermittent fastingBEHAVIORAL1

Leading sponsors

David D'Alessio, M.D.2Christian Medical College, Vellore, India1University Hospital Tuebingen1University of Southern California1VA Office of Research and Development1

Trial status mix

COMPLETED4

RECRUITING1

TERMINATED1

Phase mix

NA2

PHASE12

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.